Beta 2 glycoprotein-I antigen is increased in primary hyperlipidaemia

Area of Science:

• Cardiovascular Science
• Clinical Chemistry
• Immunology

Background:

• Beta 2 glycoprotein-I (beta 2GPI) is an important plasma protein.
• Hyperlipidaemia is a significant risk factor for cardiovascular diseases.
• The relationship between beta 2GPI and plasma lipids requires further investigation.

Purpose of the Study:

• To investigate the association between elevated beta 2 glycoprotein-I (beta 2GPI) levels and primary hyperlipidaemia.
• To determine if plasma lipid profiles influence beta 2GPI antigen levels.

Main Methods:

• Quantitative measurement of plasma beta 2GPI antigen levels.
• Analysis of 47 patients with primary hyperlipidaemia (hypercholesterolaemia, hypertriglyceridaemia, mixed hyperlipidaemia) and 34 healthy controls.
• Statistical analysis to assess correlations between beta 2GPI and lipid levels (triglycerides, total cholesterol).

Main Results:

• Significantly increased mean beta 2GPI levels were observed in all hyperlipidaemia patient groups compared to controls (P < 0.01).
• Correlations between beta 2GPI and lipid levels were found in controls but not consistently across all patient groups.
• Beta 2GPI levels were elevated in hyperlipidaemia, with perturbed distribution across plasma lipid fractions.

Conclusions:

• Beta 2 glycoprotein-I (beta 2GPI) is elevated in patients with hyperlipidaemia.
• Plasma lipid levels can affect the interpretation of beta 2GPI antigen assay results.
• Consideration of plasma lipid profiles is recommended when assessing beta 2GPI levels.